Literature DB >> 21403836

Identification of H-Ras-specific motif for the activation of invasive signaling program in human breast epithelial cells.

Hae-Young Yong1, Jin-Sun Hwang, Hwajin Son, Hae-In Park, Eok-Soo Oh, Hyun-Hwi Kim, Do Kyun Kim, Wahn Soo Choi, Bong-Jin Lee, Hyeong-Reh Choi Kim, Aree Moon.   

Abstract

Increased expression and/or activation of H-Ras are often associated with tumor aggressiveness in breast cancer. Previously, we showed that H-Ras, but not N-Ras, induces MCF10A human breast epithelial cell invasion and migration, whereas both H-Ras and N-Ras induce cell proliferation and phenotypic transformation. In an attempt to determine the sequence requirement directing the divergent phenotype induced by H-Ras and N-Ras with a focus on the induction of human breast cell invasion, we investigated the structural and functional relationships between H-Ras and N-Ras using domain-swap and site-directed mutagenesis approaches. Here, we report that the hypervariable region (HVR), consisting of amino acids 166 to 189 in H-Ras, determines the invasive/migratory signaling program as shown by the exchange of invasive phenotype by swapping HVR sequences between H-Ras and N-Ras. We also demonstrate that the H-Ras-specific additional palmitoylation site at Cys184 is not responsible for the signaling events that distinguish between H-Ras and N-Ras. Importantly, this work identifies the C-terminal HVR, especially the flexible linker domain with two consecutive proline residues Pro173 and Pro174, as a critical domain that contributes to activation of H-Ras and its invasive potential in human breast epithelial cells. The present study sheds light on the structural basis for the Ras isoform-specific invasive program of breast epithelial cells, providing information for the development of agents that specifically target invasion-related H-Ras pathways in human cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21403836      PMCID: PMC3033589          DOI: 10.1593/neo.101088

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  42 in total

1.  Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins.

Authors:  M V Milburn; L Tong; A M deVos; A Brünger; Z Yamaizumi; S Nishimura; S H Kim
Journal:  Science       Date:  1990-02-23       Impact factor: 47.728

Review 2.  Aberrant function of the Ras signal transduction pathway in human breast cancer.

Authors:  G J Clark; C J Der
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

3.  All ras proteins are polyisoprenylated but only some are palmitoylated.

Authors:  J F Hancock; A I Magee; J E Childs; C J Marshall
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

4.  The p21 ras C-terminus is required for transformation and membrane association.

Authors:  B M Willumsen; A Christensen; N L Hubbert; A G Papageorge; D R Lowy
Journal:  Nature       Date:  1984 Aug 16-22       Impact factor: 49.962

5.  p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells.

Authors:  Mi-Sung Kim; Eun-Jung Lee; Hyeong-Reh Choi Kim; Aree Moon
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

6.  MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.

Authors:  Ulrike Stein; Wolfgang Walther; Franziska Arlt; Holger Schwabe; Janice Smith; Iduna Fichtner; Walter Birchmeier; Peter M Schlag
Journal:  Nat Med       Date:  2008-12-21       Impact factor: 53.440

7.  Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.

Authors:  Aree Moon; Hae-Young Yong; Jae-In Song; Daniela Cukovic; Sridevi Salagrama; David Kaplan; David Putt; Hyesook Kim; Alan Dombkowski; Hyeong-Reh Choi Kim
Journal:  Mol Cancer Res       Date:  2008-10       Impact factor: 5.852

Review 8.  Structural basis for the role in protein folding of conserved proline-rich regions in cytochromes P450.

Authors:  Byron Kemper
Journal:  Toxicol Appl Pharmacol       Date:  2004-09-15       Impact factor: 4.219

Review 9.  Palmitoyl acyltransferase assays and inhibitors (Review).

Authors:  Jeremiah M Draper; Charles D Smith
Journal:  Mol Membr Biol       Date:  2009-01-16       Impact factor: 2.857

Review 10.  Ras proteins: paradigms for compartmentalised and isoform-specific signalling.

Authors:  J Omerovic; A J Laude; I A Prior
Journal:  Cell Mol Life Sci       Date:  2007-10       Impact factor: 9.261

View more
  16 in total

1.  Ras-related tumorigenesis is suppressed by BNIP3-mediated autophagy through inhibition of cell proliferation.

Authors:  Shan-Ying Wu; Sheng-Hui Lan; Da-En Cheng; Wei-Kai Chen; Cheng-Huang Shen; Ying-Ray Lee; Roberto Zuchini; Hsiao-Sheng Liu
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

3.  Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H-Ras-induced epithelial to mesenchymal transition.

Authors:  Minsoo Koh; Yunjung Woo; Rajeshwari R Valiathan; Hae Yoen Jung; So Yeon Park; Yong Nyun Kim; Hyeong-Reh Choi Kim; Rafael Fridman; Aree Moon
Journal:  Int J Cancer       Date:  2014-08-30       Impact factor: 7.396

4.  Ras Signaling in Breast Cancer.

Authors:  Aree Moon
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

Review 6.  Role of p38 MAP Kinase Signal Transduction in Solid Tumors.

Authors:  Hari K Koul; Mantu Pal; Sweaty Koul
Journal:  Genes Cancer       Date:  2013-09

7.  Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

8.  A novel model to combine clinical and pathway-based transcriptomic information for the prognosis prediction of breast cancer.

Authors:  Sijia Huang; Cameron Yee; Travers Ching; Herbert Yu; Lana X Garmire
Journal:  PLoS Comput Biol       Date:  2014-09-18       Impact factor: 4.475

9.  High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site.

Authors:  Tanmay S Chavan; Hyunbum Jang; Lyuba Khavrutskii; Sherwin J Abraham; Avik Banerjee; Benjamin C Freed; Liv Johannessen; Sergey G Tarasov; Vadim Gaponenko; Ruth Nussinov; Nadya I Tarasova
Journal:  Biophys J       Date:  2015-12-15       Impact factor: 4.033

Review 10.  Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated Proteins.

Authors:  Raymond R Mattingly
Journal:  ISRN Oncol       Date:  2013-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.